Listed

NovaBridge Biosciences

NBPNasdaqCIK 1778016HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$210.6m, FY2025
Shareholders' equity$230.9m, FY2025
Line itemUnitFY20192019-12-31FY20202020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$m163Cash and equivalents, FY2019, at 2019-12-31$163.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2020-04-29, accession 0001193125-20-124785.Report this figure729Cash and equivalents, FY2020, at 2020-12-31$729.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2021-04-28, accession 0001193125-21-135440.Report this figure553Cash and equivalents, FY2021, at 2021-12-31$552.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2022-04-29, accession 0001193125-22-133550.Report this figure343Cash and equivalents, FY2022, at 2022-12-31$342.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2025-04-03, accession 0000950170-25-050344.Report this figure292Cash and equivalents, FY2023, at 2023-12-31$291.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure68.3Cash and equivalents, FY2024, at 2024-12-31$68.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure211Cash and equivalents, FY2025, at 2025-12-31$210.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure
Current assets$m196Current assets, FY2019, at 2019-12-31$195.5m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2020-04-29, accession 0001193125-20-124785.Report this figure819Current assets, FY2020, at 2020-12-31$819.0m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2021-04-28, accession 0001193125-21-135440.Report this figure750Current assets, FY2021, at 2021-12-31$750.4m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2022-04-29, accession 0001193125-22-133550.Report this figure526Current assets, FY2022, at 2022-12-31$525.8m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2023-05-01, accession 0001104659-23-053462.Report this figure330Current assets, FY2023, at 2023-12-31$329.9m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2025-04-03, accession 0000950170-25-050344.Report this figure177Current assets, FY2024, at 2024-12-31$176.7m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure218Current assets, FY2025, at 2025-12-31$217.5m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure
Total assets$m250Total assets, FY2019, at 2019-12-31$249.6m. XBRL concept us-gaap:Assets. 20-F filed 2020-04-29, accession 0001193125-20-124785.Report this figure971Total assets, FY2020, at 2020-12-31$970.7m. XBRL concept us-gaap:Assets. 20-F filed 2021-04-28, accession 0001193125-21-135440.Report this figure879Total assets, FY2021, at 2021-12-31$878.9m. XBRL concept us-gaap:Assets. 20-F filed 2022-04-29, accession 0001193125-22-133550.Report this figure591Total assets, FY2022, at 2022-12-31$590.6m. XBRL concept us-gaap:Assets. 20-F filed 2023-05-01, accession 0001104659-23-053462.Report this figure369Total assets, FY2023, at 2023-12-31$368.9m. XBRL concept us-gaap:Assets. 20-F filed 2025-04-03, accession 0000950170-25-050344.Report this figure213Total assets, FY2024, at 2024-12-31$212.7m. XBRL concept us-gaap:Assets. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure261Total assets, FY2025, at 2025-12-31$260.5m. XBRL concept us-gaap:Assets. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure
Current liabilities$m84.5Current liabilities, FY2019, at 2019-12-31$84.5m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2020-04-29, accession 0001193125-20-124785.Report this figure88.3Current liabilities, FY2020, at 2020-12-31$88.3m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2021-04-28, accession 0001193125-21-135440.Report this figure97.9Current liabilities, FY2021, at 2021-12-31$97.9m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2022-04-29, accession 0001193125-22-133550.Report this figure110Current liabilities, FY2022, at 2022-12-31$109.9m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2023-05-01, accession 0001104659-23-053462.Report this figure58.1Current liabilities, FY2023, at 2023-12-31$58.1m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2025-04-03, accession 0000950170-25-050344.Report this figure8.5Current liabilities, FY2024, at 2024-12-31$8.5m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure26.9Current liabilities, FY2025, at 2025-12-31$26.9m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure
Total liabilities$m96.0Total liabilities, FY2019, at 2019-12-31$96.0m. XBRL concept us-gaap:Liabilities. 20-F filed 2020-04-29, accession 0001193125-20-124785.Report this figure108Total liabilities, FY2020, at 2020-12-31$108.3m. XBRL concept us-gaap:Liabilities. 20-F filed 2021-04-28, accession 0001193125-21-135440.Report this figure163Total liabilities, FY2021, at 2021-12-31$163.5m. XBRL concept us-gaap:Liabilities. 20-F filed 2022-04-29, accession 0001193125-22-133550.Report this figure169Total liabilities, FY2022, at 2022-12-31$168.7m. XBRL concept us-gaap:Liabilities. 20-F filed 2023-05-01, accession 0001104659-23-053462.Report this figure126Total liabilities, FY2023, at 2023-12-31$126.3m. XBRL concept us-gaap:Liabilities. 20-F filed 2025-04-03, accession 0000950170-25-050344.Report this figure11.5Total liabilities, FY2024, at 2024-12-31$11.5m. XBRL concept us-gaap:Liabilities. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure29.6Total liabilities, FY2025, at 2025-12-31$29.6m. XBRL concept us-gaap:Liabilities. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure
Short-term borrowings$m7.2Short-term borrowings, FY2019, at 2019-12-31$7.2m. XBRL concept us-gaap:ShortTermBorrowings. 20-F filed 2020-04-29, accession 0001193125-20-124785.Report this figurenot reportednot reported2.7Short-term borrowings, FY2022, at 2022-12-31$2.7m. XBRL concept us-gaap:ShortTermBorrowings. 20-F filed 2023-05-01, accession 0001104659-23-053462.Report this figure4.2Short-term borrowings, FY2023, at 2023-12-31$4.2m. XBRL concept us-gaap:ShortTermBorrowings. 20-F filed 2024-04-30, accession 0001104659-24-054452.Report this figurenot reportednot reported
Shareholders' equity$m(292)Shareholders' equity, FY2019, at 2019-12-31−$292.3m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2020-04-29, accession 0001193125-20-124785.Report this figure862Shareholders' equity, FY2020, at 2020-12-31$862.4m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2021-04-28, accession 0001193125-21-135440.Report this figure715Shareholders' equity, FY2021, at 2021-12-31$715.1m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2025-04-03, accession 0000950170-25-050344.Report this figure418Shareholders' equity, FY2022, at 2022-12-31$417.8m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure243Shareholders' equity, FY2023, at 2023-12-31$242.6m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure201Shareholders' equity, FY2024, at 2024-12-31$201.2m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure231Shareholders' equity, FY2025, at 2025-12-31$230.9m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-04-07, accession 0001778016-26-000002.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.